Autolus Therapeutics Ltd (AUTL)vsRevolution Medicines Inc (RVMD)
AUTL
Autolus Therapeutics Ltd
$1.58
-3.07%
HEALTHCARE · Cap: $423.20M
RVMD
Revolution Medicines Inc
$190.27
+0.82%
HEALTHCARE · Cap: $38.14B
Smart Verdict
WallStSmart Research — data-driven comparison
Autolus Therapeutics Ltd generates 15721% more annual revenue ($117.39M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -238.6%. AUTL earns a higher WallStSmart Score of 32/100 (F).
AUTL
Avoid32
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 118.4% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
Weak financial health signals
Trading at 15.6x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : AUTL
The strongest argument for AUTL centers on Revenue Growth. Revenue growth of 118.4% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : AUTL
The primary concerns for AUTL are EPS Growth, Market Cap, Debt/Equity.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
AUTL profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
AUTL carries more volatility with a beta of 2.14 — expect wider price swings.
AUTL is growing revenue faster at 118.4% — sustainability is the question.
AUTL generates stronger free cash flow (-26M), providing more financial flexibility.
Bottom Line
AUTL scores higher overall (32/100 vs 24/100) and 118.4% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Autolus Therapeutics Ltd
HEALTHCARE · BIOTECHNOLOGY · USA
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T-cell therapies for the treatment of cancer. The company is headquartered in London, the United Kingdom.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?